Sprint Bioscience AB (publ) (SPRINT.ST)

SEK 1.6

(0.25%)

Net Income Summary of Sprint Bioscience AB (publ)

  • Sprint Bioscience AB (publ)'s latest annual net income in 2023 was -438 Thousand SEK , up 99.27% from previous year.
  • Sprint Bioscience AB (publ)'s latest quarterly net income in 2024 Q2 was -5.78 Million SEK , down -88.31% from previous quarter.
  • Sprint Bioscience AB (publ) reported an annual net income of -60.17 Million SEK in 2022, down -137.34% from previous year.
  • Sprint Bioscience AB (publ) reported an annual net income of -25.35 Million SEK in 2021, up 45.16% from previous year.
  • Sprint Bioscience AB (publ) reported a quarterly net income of -5.2 Million SEK for 2024 Q3, up 9.96% from previous quarter.
  • Sprint Bioscience AB (publ) reported a quarterly net income of -3.07 Million SEK for 2024 Q1, up 39.08% from previous quarter.

Annual Net Income Chart of Sprint Bioscience AB (publ) (2023 - 2011)

Historical Annual Net Income of Sprint Bioscience AB (publ) (2023 - 2011)

Year Net Income Net Income Growth
2023 -438 Thousand SEK 99.27%
2022 -60.17 Million SEK -137.34%
2021 -25.35 Million SEK 45.16%
2020 -46.23 Million SEK -103.28%
2019 -22.74 Million SEK -2.38%
2018 -22.21 Million SEK -108.35%
2017 -10.66 Million SEK -334.82%
2016 4.54 Million SEK 129.3%
2015 -15.5 Million SEK -35.21%
2014 -11.46 Million SEK -161.31%
2013 -4.38 Million SEK -23.74%
2012 -3.54 Million SEK -157.48%
2011 -1.37 Million SEK 0.0%

Peer Net Income Comparison of Sprint Bioscience AB (publ)

Name Net Income Net Income Difference
Alligator Bioscience AB (publ) -248.58 Million SEK 99.824%
Ziccum AB (publ) -21.41 Million SEK 97.954%
Modus Therapeutics Holding AB (publ) -17.89 Million SEK 97.553%
BioArctic AB (publ) 229.24 Million SEK 100.191%
Mendus AB (publ) -101.61 Million SEK 99.569%
Genovis AB (publ.) 61.5 Million SEK 100.712%
Intervacc AB (publ) -102.85 Million SEK 99.574%
QuiaPEG Pharmaceuticals Holding AB (publ) -16.52 Million SEK 97.349%
Active Biotech AB (publ) -45.8 Million SEK 99.044%
Magle Chemoswed Holding AB (publ) 12.16 Million SEK 103.599%
Bio-Works Technologies AB (publ) -56.82 Million SEK 99.229%
Aptahem AB (publ) -11.11 Million SEK 96.059%
Vicore Pharma Holding AB (publ) -310.94 Million SEK 99.859%
Kancera AB (publ) -64.88 Million SEK 99.325%
Infant Bacterial Therapeutics AB (publ) -123.06 Million SEK 99.644%
Fluicell AB (publ) -26.55 Million SEK 98.351%
Saniona AB (publ) -95.81 Million SEK 99.543%
Lipigon Pharmaceuticals AB (publ) -12.12 Million SEK 96.389%
Biovica International AB (publ) -124.82 Million SEK 99.649%
Spago Nanomedical AB (publ) -42.22 Million SEK 98.963%
AcouSort AB (publ) -17.08 Million SEK 97.437%
Xintela AB (publ) -54.08 Million SEK 99.19%
Abliva AB (publ) -95.5 Million SEK 99.541%
Egetis Therapeutics AB (publ) -326.9 Million SEK 99.866%
Karolinska Development AB (publ) 5.38 Million SEK 108.132%
OncoZenge AB (publ) -15.9 Million SEK 97.246%
Amniotics AB (publ) -30.87 Million SEK 98.581%
2cureX AB (publ) -32.51 Million SEK 98.653%
CombiGene AB (publ) -35.66 Million SEK 98.772%
Asarina Pharma AB (publ) -12.82 Million SEK 96.586%
Calliditas Therapeutics AB (publ) -466.18 Million SEK 99.906%
Camurus AB (publ) 431.44 Million SEK 100.102%
Corline Biomedical AB -1.8 Million SEK 75.788%
IRLAB Therapeutics AB (publ) -177.83 Million SEK 99.754%
Isofol Medical AB (publ) -37.07 Million SEK 98.818%
I-Tech AB 20.2 Million SEK 102.168%
Hansa Biopharma AB (publ) -831.72 Million SEK 99.947%
Cyxone AB (publ) -22.98 Million SEK 98.095%
ExpreS2ion Biotech Holding AB (publ) -91.4 Million SEK 99.521%
Biosergen AB -27.03 Million SEK 98.38%
Cantargia AB (publ) -280.02 Million SEK 99.844%
NextCell Pharma AB -41.95 Million SEK 98.956%
Xspray Pharma AB (publ) -179.66 Million SEK 99.756%
Elicera Therapeutics AB (publ) -16.39 Million SEK 97.329%
Nanologica AB (publ) -75.15 Million SEK 99.417%
SynAct Pharma AB -215.81 Million SEK 99.797%
Annexin Pharmaceuticals AB (publ) -44.05 Million SEK 99.006%
Stayble Therapeutics AB (publ) -23.73 Million SEK 98.155%
LIDDS AB (publ) -40.2 Million SEK 98.911%
Lipum AB (publ) -37.17 Million SEK 98.822%
BioInvent International AB (publ) -330.3 Million SEK 99.867%
Alzinova AB (publ) -16.48 Million SEK 97.342%
Oncopeptides AB (publ) -249.11 Million SEK 99.824%
Pila Pharma AB (publ) -9.93 Million SEK 95.589%
Guard Therapeutics International AB (publ) -113.32 Million SEK 99.613%
Scandinavian ChemoTech AB (publ) -21.09 Million SEK 97.923%
Simris Alg AB (publ) -37.3 Million SEK 98.826%
Diamyd Medical AB (publ) -151.85 Million SEK 99.712%
Xbrane Biopharma AB (publ) -388.17 Million SEK 99.887%
Ascelia Pharma AB (publ) -109.28 Million SEK 99.599%
Diagonal Bio AB (publ) -11.67 Million SEK 96.249%